REAL-LIFE STUDY OF BIO-CLINICAL FOLLOW-UP AFTER BNT162b2 mRNA COVID-19 (BNTCV) VACCINATION IN 235 PATIENTS (PTS) INCLUDING 225 WITH HEMATOLOGICAL MALIGNANCIES (HM). Jean-François Rossi; Emmanuel Bonnet; Marion Velensek; Emma Wisniewski; Sophie Heraud; Rania Boustany; Céleste David; Jérôme Dinet; Roland Sicard; Jean-Pierre Daures; Marion Bonifacy; Lysiane Mousset; Christel Castelli; Emmanuel Goffart;

FROM ALLOGENIC TRANSPLANTATION TO PRECISION IMMUNE THERAPY Jean-François Rossi;